Archer Aviation Just Hit a Major Milestone -- But Investors Should Watch This One Key Metric Next

Archer Aviation achieved 100% FAA acceptance of its Means of Compliance for the Midnight aircraft, a key regulatory milestone toward commercial certification. The company also exited 2025 with nearly $2 billion in liquidity, giving it time to complete certification and scale production, but it still has minimal revenue and is burning hundreds of millions annually. The article frames the stock as a high-risk execution story, with the next 12 months centered on on-time commercial operations and manufacturing scale-up.

Analysis

The key market change is not the regulatory milestone itself, but the probability shift it creates across the financing stack. Once certification risk starts to compress, ACHR transitions from a binary science project to a capital-allocation story, which typically rerates peers unevenly: the better-funded, faster-credible platform attracts incremental capital while weaker names face higher dilution pressure. That is the first-order reason ACHR likely gains relative to JOBY over the next 6-12 months if execution stays clean.

The second-order risk is that the market may overestimate how much a “means of compliance” win de-risks commercialization. The next bottleneck is no longer FAA philosophy; it is manufacturing yield, supply-chain repeatability, and operating economics in a still-unproven category. Any delay in first paid flights or early unit economics deterioration would likely hit the stock harder than before because the market has already started pricing in a certification glide path.

The liquidity cushion is supportive, but it also changes incentives: with enough cash, management can optimize for timeline rather than capital efficiency, which often leads to margin dilution and higher opex as companies rush to preserve narrative momentum. For investors, the more interesting setup is not outright long ACHR on fundamentals, but a dispersion trade around who can convert regulatory progress into actual revenue first. In that sense, the consensus may be underappreciating how quickly patience can reverse if commercial launch slippage turns into another 2-3 quarter delay cycle.

Key Decisions for Investors

• Long ACHR / short JOBY as a 6-12 month relative-value trade if you believe Archer’s funding runway and regulatory alignment improve the odds of faster commercialization; target a 1.5-2.0x gross return on the spread if ACHR continues to de-risk while JOBY remains execution-dependent.
• Avoid chasing outright ACHR strength after the milestone; wait for a pullback or failed breakout and buy only on confirmation of paid customer activity, since the stock is now more sensitive to execution misses than to good news.
• Buy ACHR Jan-2027 call spreads instead of common stock to express upside from a successful first-commercialization window while capping downside from dilution or timeline slippage; favorable if you expect volatility to stay elevated.
• Short-dated hedge: buy ACHR puts into any additional certification headlines if the stock gaps sharply, as event-driven exuberance can unwind quickly if the market realizes certification is necessary but not sufficient.
• Monitor for secondary equity issuance across eVTOL peers over the next 2-4 quarters; any fresh capital raise from a weaker competitor would support a relative long ACHR thesis by tightening the funding gap and accelerating winner-take-most dynamics.